Low volume cancer is significant because it often correlates with a more favorable prognosis. Patients with low volume disease usually have more treatment options available and may respond better to therapies. For example, low volume prostate cancer is often more amenable to localized treatments such as surgery or radiation, whereas high volume disease might require systemic therapies like chemotherapy or hormone therapy.
